The global endoscopic vessel harvesting systems market is entering a promising growth phase, anticipated to expand steadily from USD 577.1 million in 2025 to USD 949.0 million by 2035, registering a compound annual growth rate (CAGR) of 5.1%. This steady climb reflects the growing adoption of minimally invasive surgical procedures and the rising global prevalence …
Monthly Archives: April 2025
Global Intraoperative Radiation Therapy Systems Market to Witness Robust Growth to Reach USD 124.7 Million by 2033
The global intraoperative radiation therapy systems market is poised for significant growth, with projections indicating a substantial increase in value over the next decade. According to recent market analysis, the market, valued at USD 59.3 million in 2023, is anticipated to expand at a Compound Annual Growth Rate (CAGR) of 7.7% from 2023 to 2033, …
Turning the Tide in Brain Cancer: The Future of Glioblastoma Treatment Drugs Market | FMI
The global glioblastoma treatment drugs market is on the cusp of transformative growth. With market revenues expected to surge from approximately USD 844.8 million in 2025 to a projected USD 1,470.5 million by 2035, the sector is poised for a Compound Annual Growth Rate (CAGR) of 5.7% over the decade. By 2024, the market had …
Implantable Infusion Pump Market: Fueling the Future of Targeted Drug Delivery | FMI
The global healthcare industry continues to evolve at an extraordinary pace, driven by advancements in medical technology and the ever-growing demand for personalized treatment solutions. Among the innovations reshaping patient care, implantable infusion pumps have emerged as a game-changer in targeted drug delivery. According to the latest projections, the global implantable infusion pump market is …
Global Hemostasis Testing Systems Market: A Rapidly Advancing Frontier in Diagnostic Technology | FMI
The global market for hemostasis testing systems is undergoing a dynamic transformation, fueled by technological innovation, increasing prevalence of bleeding and thrombotic disorders, and an expanding aging population. Valued at USD 2,366.1 million in 2025, the market is projected to grow at a CAGR of 5.4%, reaching USD 3,998.0 million by 2035. The strategic shift …
Riding the Digital Wave: Healthcare IT Outsourcing Market Set for Robust Growth from 2025 to 2035
The global healthcare sector stands at the crossroads of innovation and necessity. As organizations across the healthcare spectrum face mounting pressure to improve patient outcomes, streamline operations, and reduce costs, one trend is emerging as a clear strategic enabler—healthcare IT outsourcing. Between 2025 and 2035, the healthcare IT outsourcing market is projected to grow significantly, …
Graft Versus Host Disease (GvHD) Treatment Market Projected to Reach USD 5,585.2 Million by 2035, Driven by Innovative Therapies and Expanding Transplant Rates | FMI
The global graft versus host disease treatment market is poised for substantial growth, rising from approximately USD 2,881.8 million in 2024 to an estimated USD 3,060.5 million by 2025, and further projected to attain USD 5,585.2 million by 2035, reflecting a steady CAGR of 6.2%. As stem cell transplantation becomes increasingly central to hematologic cancer …
Global Equine Veterinary Therapeutics Market Set to Surpass USD 3,047.6 Million by 2035 amidst Surge in Advanced Therapies and Equine Healthcare Awareness | FMI
The global equine veterinary therapeutics market is galloping towards impressive growth, projected to reach approximately USD 1,572.6 million by 2025 and further expand to around USD 3,047.6 million by 2035. This remarkable trajectory, at a compound annual growth rate (CAGR) of 6.8%, underscores a robust and transforming industry increasingly driven by innovation, awareness, and precision …
Global Glucose Sensor Market Set to Surpass USD 20,421.4 Million by 2034 Amid Rising Diabetes Concerns | FMI
The global glucose sensor market is projected to witness substantial growth, reaching a valuation of USD 20,421.4 million by 2034, according to a recent report. The market, currently valued at USD 8,949.3 million in 2024, is anticipated to expand at a CAGR of 8.6% from 2024 to 2034. Rising concerns over the escalating prevalence of …
Global Glaucoma Therapeutics Market Set to Reach USD 10.2 Million by 2032, Driven by Aging Population and Technological Advancements in Treatment | FMI
The global glaucoma therapeutics market, valued at USD 6.9 million in 2022, is poised to grow at a steady CAGR of 3.7% over the next decade, reaching approximately USD 10.2 million by 2032. The market’s expansion is attributed to rising geriatric demographics, improved diagnostic technologies, and increased awareness of glaucoma treatment options. Glaucoma, one of …